Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | serine | 6702 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 8902 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 9030 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 9939 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 10053 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | serine | 10091 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 10141 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 10348 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 10565 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 10584 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | serine | 10686 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 10717 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 10732 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 10762 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 10771 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 11056 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 11071 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | serine | 11309 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 11316 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 11346 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 11382 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | serine | 11383 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 11386 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 11474 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 11536 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 11543 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 11547 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 11720 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 11735 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 11757 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 11830 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 11891 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 11928 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 12005 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12041 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 12151 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 12156 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 12195 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12264 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 12339 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 12475 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12520 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12537 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12610 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 12625 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 12633 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12666 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12673 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12697 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12718 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12745 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 12777 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 12784 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12848 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12871 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 12879 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 12909 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 12929 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 12943 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 12999 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13005 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13009 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 13021 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13025 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 13117 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13122 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 13136 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13191 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13255 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 13258 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 13258 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13310 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13315 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 13328 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13337 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | serine | 13365 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | serine | 13424 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 13457 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13461 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 13496 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 13506 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13568 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 13622 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 13655 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 13687 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 13695 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 13756 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13776 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 13790 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 13838 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13865 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 13881 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 13968 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 14001 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14023 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14066 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 14112 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14129 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14132 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 14168 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14229 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 14255 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 14255 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 14387 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 14459 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | serine | 14534 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 14649 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 14653 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 14682 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14827 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14916 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 14961 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 14986 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 15041 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 15159 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 15180 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | serine | 15265 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 15316 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 15369 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 15497 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 15506 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 15537 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 15601 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 15652 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | serine | 15694 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 15695 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 15779 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 15780 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 15812 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 15828 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 15871 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 15936 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 16020 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16096 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16131 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 16137 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16146 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16161 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 16169 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16200 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 16244 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16246 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 16305 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16307 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16344 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16359 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16371 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16395 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16469 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16484 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | serine | 16520 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 16623 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16642 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16668 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16682 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 16688 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | serine | 16701 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 16716 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | serine | 16743 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 16745 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16820 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 16887 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | serine | 16931 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 16999 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | serine | 17057 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17068 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17100 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17109 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17291 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 17308 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 17421 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17471 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17511 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | serine | 17519 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17548 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17562 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | serine | 17574 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17590 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 17612 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17636 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17665 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17673 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17734 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17768 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 17774 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17783 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17804 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17814 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 17837 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | serine | 17882 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | serine | 17892 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | serine | 17949 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 17949 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | serine | 18018 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | serine | 18025 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | serine | 18120 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | serine | 18163 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | serine | 18319 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | serine | 18405 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | serine | 18411 | Counts | 50-54 | Female | Current | Adenocarcinoma |
Return to search page